{"altmetric_id":2062619,"counts":{"readers":{"mendeley":9,"citeulike":0,"connotea":0},"total":{"posts_count":2},"twitter":{"unique_users_count":1,"unique_users":["ndm1bacteria"],"posts_count":2}},"citation":{"abstract":"The post-\u03b2-lactamase-inhibitor effect (PBLIE) of tazobactam combined with ceftolozane was evaluated by time-kill assays on two clinical Escherichia coli strains producing CTX-M-15 with or without TEM-1. The organisms were exposed (2 h) to 4 \u03bcg\/ml\/4 \u03bcg\/ml of ceftolozane-tazobactam (4\u00d7 MIC), 4 \u03bcg\/ml of ceftolozane, and medium containing no drug, washed, and resuspended in medium alone or medium containing ceftolozane-tazobactam or ceftolozane. The PBLIE was determined as 1.3 to 2.1 h, and a postantibiotic effect was measured as 0.8 to 0.9 h.","abstract_source":"pubmed","altmetric_jid":"4f6fa60b3cf058f610006a6a","authors":["Helio S. Sader","Paul R. Rhomberg","Ronald N. Jones"],"doi":"10.1128\/aac.02398-13","first_seen_on":"2014-01-22T07:58:06+00:00","issns":["1098-6596"],"journal":"Antimicrobial Agents and Chemotherapy","last_mentioned_on":1390489372,"links":["http:\/\/aac.asm.org\/content\/early\/2014\/01\/14\/AAC.02398-13.abstract?maxtoshow=&HITS=10&hits=3&RESULTFORMAT=&andorexacttitle=and&andorexacttitleabs=and&fulltext=ESBL&andorexactfulltext=and&searchid=1&usestrictdates=yes&resourcetype=HWCIT&ct=","http:\/\/aac.asm.org\/content\/early\/2014\/01\/14\/AAC.02398-13.abstract?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&andorexacttitle=and&andorexacttitleabs=and&fulltext=ESBL&andorexactfulltext=and&searchid=1&usestrictdates=yes&resourcetype=HWCIT&ct="],"pdf_url":"http:\/\/aac.asm.org\/content\/early\/2014\/01\/14\/AAC.02398-13.full.pdf","pmid":"24449780","publisher":"American Society for Microbiology","publisher_subjects":[{"name":"Microbiology","scheme":"era"},{"name":"Medical Microbiology","scheme":"era"},{"name":"Pharmacology And Pharmaceutical Sciences","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Pharmacology, Toxicology and Pharmaceutics"],"subjects":["drugtherapy"],"title":"Post \u03b2-Lactamase Inhibitor Effect of Tazobactam in combination with Ceftolozane and Tested against ESBL-Producing Strains","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/postlactamaseinhibitor-effect-tazobactam-combination-ceftolozane-extendedspectrumlactamaseproducing"},"altmetric_score":{"score":0.25,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.25},"context_for_score":{"all":{"total_number_of_other_articles":3626012,"mean":4.9497445252532,"rank":2907101,"this_scored_higher_than_pct":2,"this_scored_higher_than":72771,"rank_type":"exact","sample_size":3626012,"percentile":2},"similar_age_3m":{"total_number_of_other_articles":109392,"mean":7.1606115859624,"rank":85631,"this_scored_higher_than_pct":1,"this_scored_higher_than":276,"rank_type":"exact","sample_size":109392,"percentile":1},"this_journal":{"total_number_of_other_articles":2631,"mean":3.067297338403,"rank":2055,"this_scored_higher_than_pct":2,"this_scored_higher_than":72,"rank_type":"exact","sample_size":2631,"percentile":2},"similar_age_this_journal_3m":{"total_number_of_other_articles":47,"mean":5.4874782608696,"rank":39,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":47,"percentile":1}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Professor > Associate Professor":1,"Researcher":3,"Student  > Doctoral Student":1,"Other":2,"Student  > Bachelor":1,"Unspecified":1},"by_discipline":{"Medicine and Dentistry":1,"Immunology and Microbiology":1,"Agricultural and Biological Sciences":4,"Computer Science":1,"Unspecified":2}}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/ndm1bacteria\/status\/425899934475251712","license":"public","citation_ids":[2062619],"posted_on":"2014-01-22T07:57:11+00:00","author":{"name":"Dave Roberts","url":"http:\/\/www.ndm1bacteria.com","image":"https:\/\/pbs.twimg.com\/profile_images\/1294321879\/713px-EscherichiaColi_NIAID_normal.jpg","id_on_source":"ndm1bacteria","tweeter_id":"177368473","geo":{"lt":null,"ln":null},"followers":545},"tweet_id":"425899934475251712"},{"url":"http:\/\/twitter.com\/ndm1bacteria\/status\/426369446555291650","license":"public","citation_ids":[2062619],"posted_on":"2014-01-23T15:02:52+00:00","author":{"name":"Dave Roberts","url":"http:\/\/www.ndm1bacteria.com","image":"https:\/\/pbs.twimg.com\/profile_images\/1294321879\/713px-EscherichiaColi_NIAID_normal.jpg","id_on_source":"ndm1bacteria","tweeter_id":"177368473","geo":{"lt":null,"ln":null},"followers":545},"tweet_id":"426369446555291650"}]}}